Click for best price
Erythropoietin EPO Drugs Market Size, Share 2023
It is a glycoprotein hormone that controls the production of red blood cells, or the production of red blood cells.
This report aims to provide a comprehensive presentation of the global market for Erythropoietin (EPO) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythropoietin (EPO) Drugs. This report contains market size and forecasts of Erythropoietin (EPO) Drugs in global, including the following market information:
Global Erythropoietin (EPO) Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Erythropoietin (EPO) Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Epoetin-alfa Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Erythropoietin (EPO) Drugs include Pfizer, Roche, Amgen, Johnson & Johnson, Kyowa Kirin, Shanghai Dahua Pharmaceutical, JCR Pharmaceuticals and Teva Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Erythropoietin (EPO) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erythropoietin (EPO) Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Erythropoietin (EPO) Drugs Market Segment Percentages, by Type, 2022 (%)
Epoetin-alfa
Darbepoetin-alfa
Global Erythropoietin (EPO) Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Erythropoietin (EPO) Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Homecare
Specialty Clinics
Others
Global Erythropoietin (EPO) Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Erythropoietin (EPO) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erythropoietin (EPO) Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Erythropoietin (EPO) Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Amgen
Johnson & Johnson
Kyowa Kirin
Shanghai Dahua Pharmaceutical
JCR Pharmaceuticals
Teva Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Erythropoietin (EPO) Drugs, market overview.
Chapter 2: Global Erythropoietin (EPO) Drugs market size in revenue.
Chapter 3: Detailed analysis of Erythropoietin (EPO) Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Erythropoietin (EPO) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Erythropoietin (EPO) Drugs Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Erythropoietin (EPO) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Erythropoietin (EPO) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Erythropoietin (EPO) Drugs Overall Market Size
2.1 Global Erythropoietin (EPO) Drugs Market Size: 2022 VS 2032
2.2 Global Erythropoietin (EPO) Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Erythropoietin (EPO) Drugs Players in Global Market
3.2 Top Global Erythropoietin (EPO) Drugs Companies Ranked by Revenue
3.3 Global Erythropoietin (EPO) Drugs Revenue by Companies
3.4 Top 3 and Top 5 Erythropoietin (EPO) Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Erythropoietin (EPO) Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Erythropoietin (EPO) Drugs Players in Global Market
3.6.1 List of Global Tier 1 Erythropoietin (EPO) Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Erythropoietin (EPO) Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Erythropoietin (EPO) Drugs Market Size Markets, 2022 & 2032
4.1.2 Epoetin-alfa
4.1.3 Darbepoetin-alfa
4.2 By Type - Global Erythropoietin (EPO) Drugs Revenue & Forecasts
4.2.1 By Type - Global Erythropoietin (EPO) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Erythropoietin (EPO) Drugs Revenue, 2024-2032
4.2.3 By Type - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Erythropoietin (EPO) Drugs Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Homecare
5.1.4 Specialty Clinics
5.1.5 Others
5.2 By Application - Global Erythropoietin (EPO) Drugs Revenue & Forecasts
5.2.1 By Application - Global Erythropoietin (EPO) Drugs Revenue, 2018-2023
5.2.2 By Application - Global Erythropoietin (EPO) Drugs Revenue, 2024-2032
5.2.3 By Application - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Erythropoietin (EPO) Drugs Market Size, 2022 & 2032
6.2 By Region - Global Erythropoietin (EPO) Drugs Revenue & Forecasts
6.2.1 By Region - Global Erythropoietin (EPO) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Erythropoietin (EPO) Drugs Revenue, 2024-2032
6.2.3 By Region - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Erythropoietin (EPO) Drugs Revenue, 2018-2032
6.3.2 US Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.3.3 Canada Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.3.4 Mexico Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Erythropoietin (EPO) Drugs Revenue, 2018-2032
6.4.2 Germany Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.4.3 France Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.4.4 U.K. Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.4.5 Italy Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.4.6 Russia Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.4.8 Benelux Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Erythropoietin (EPO) Drugs Revenue, 2018-2032
6.5.2 China Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.5.3 Japan Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.5.4 South Korea Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.5.6 India Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Erythropoietin (EPO) Drugs Revenue, 2018-2032
6.6.2 Brazil Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.6.3 Argentina Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Erythropoietin (EPO) Drugs Revenue, 2018-2032
6.7.2 Turkey Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.7.3 Israel Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Erythropoietin (EPO) Drugs Market Size, 2018-2032
6.7.5 UAE Erythropoietin (EPO) Drugs Market Size, 2018-2032
7 Erythropoietin (EPO) Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Erythropoietin (EPO) Drugs Major Product Offerings
7.1.4 Pfizer Erythropoietin (EPO) Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Erythropoietin (EPO) Drugs Major Product Offerings
7.2.4 Roche Erythropoietin (EPO) Drugs Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Amgen
7.3.1 Amgen Company Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Erythropoietin (EPO) Drugs Major Product Offerings
7.3.4 Amgen Erythropoietin (EPO) Drugs Revenue in Global Market (2018-2023)
7.3.5 Amgen Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Erythropoietin (EPO) Drugs Major Product Offerings
7.4.4 Johnson & Johnson Erythropoietin (EPO) Drugs Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Kyowa Kirin
7.5.1 Kyowa Kirin Company Summary
7.5.2 Kyowa Kirin Business Overview
7.5.3 Kyowa Kirin Erythropoietin (EPO) Drugs Major Product Offerings
7.5.4 Kyowa Kirin Erythropoietin (EPO) Drugs Revenue in Global Market (2018-2023)
7.5.5 Kyowa Kirin Key News & Latest Developments
7.6 Shanghai Dahua Pharmaceutical
7.6.1 Shanghai Dahua Pharmaceutical Company Summary
7.6.2 Shanghai Dahua Pharmaceutical Business Overview
7.6.3 Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Major Product Offerings
7.6.4 Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Revenue in Global Market (2018-2023)
7.6.5 Shanghai Dahua Pharmaceutical Key News & Latest Developments
7.7 JCR Pharmaceuticals
7.7.1 JCR Pharmaceuticals Company Summary
7.7.2 JCR Pharmaceuticals Business Overview
7.7.3 JCR Pharmaceuticals Erythropoietin (EPO) Drugs Major Product Offerings
7.7.4 JCR Pharmaceuticals Erythropoietin (EPO) Drugs Revenue in Global Market (2018-2023)
7.7.5 JCR Pharmaceuticals Key News & Latest Developments
7.8 Teva Pharmaceuticals
7.8.1 Teva Pharmaceuticals Company Summary
7.8.2 Teva Pharmaceuticals Business Overview
7.8.3 Teva Pharmaceuticals Erythropoietin (EPO) Drugs Major Product Offerings
7.8.4 Teva Pharmaceuticals Erythropoietin (EPO) Drugs Revenue in Global Market (2018-2023)
7.8.5 Teva Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Erythropoietin (EPO) Drugs Market Opportunities & Trends in Global Market
Table 2. Erythropoietin (EPO) Drugs Market Drivers in Global Market
Table 3. Erythropoietin (EPO) Drugs Market Restraints in Global Market
Table 4. Key Players of Erythropoietin (EPO) Drugs in Global Market
Table 5. Top Erythropoietin (EPO) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Erythropoietin (EPO) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Erythropoietin (EPO) Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Erythropoietin (EPO) Drugs Product Type
Table 9. List of Global Tier 1 Erythropoietin (EPO) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Erythropoietin (EPO) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Erythropoietin (EPO) Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Erythropoietin (EPO) Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Erythropoietin (EPO) Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Erythropoietin (EPO) Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Erythropoietin (EPO) Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Erythropoietin (EPO) Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2024-2032
Table 30. Pfizer Company Summary
Table 31. Pfizer Erythropoietin (EPO) Drugs Product Offerings
Table 32. Pfizer Erythropoietin (EPO) Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Erythropoietin (EPO) Drugs Product Offerings
Table 36. Roche Erythropoietin (EPO) Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Amgen Company Summary
Table 39. Amgen Erythropoietin (EPO) Drugs Product Offerings
Table 40. Amgen Erythropoietin (EPO) Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Amgen Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Erythropoietin (EPO) Drugs Product Offerings
Table 44. Johnson & Johnson Erythropoietin (EPO) Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Kyowa Kirin Company Summary
Table 47. Kyowa Kirin Erythropoietin (EPO) Drugs Product Offerings
Table 48. Kyowa Kirin Erythropoietin (EPO) Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Kyowa Kirin Key News & Latest Developments
Table 50. Shanghai Dahua Pharmaceutical Company Summary
Table 51. Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Product Offerings
Table 52. Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Shanghai Dahua Pharmaceutical Key News & Latest Developments
Table 54. JCR Pharmaceuticals Company Summary
Table 55. JCR Pharmaceuticals Erythropoietin (EPO) Drugs Product Offerings
Table 56. JCR Pharmaceuticals Erythropoietin (EPO) Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. JCR Pharmaceuticals Key News & Latest Developments
Table 58. Teva Pharmaceuticals Company Summary
Table 59. Teva Pharmaceuticals Erythropoietin (EPO) Drugs Product Offerings
Table 60. Teva Pharmaceuticals Erythropoietin (EPO) Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Teva Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Erythropoietin (EPO) Drugs Segment by Type in 2022
Figure 2. Erythropoietin (EPO) Drugs Segment by Application in 2022
Figure 3. Global Erythropoietin (EPO) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Erythropoietin (EPO) Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Erythropoietin (EPO) Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Erythropoietin (EPO) Drugs Revenue in 2022
Figure 8. By Type - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Erythropoietin (EPO) Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Erythropoietin (EPO) Drugs Revenue Market Share, 2018-2032
Figure 16. US Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Erythropoietin (EPO) Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Erythropoietin (EPO) Drugs Revenue Market Share, 2018-2032
Figure 28. China Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Erythropoietin (EPO) Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Erythropoietin (EPO) Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Erythropoietin (EPO) Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. Pfizer Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Amgen Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Kyowa Kirin Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Shanghai Dahua Pharmaceutical Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. JCR Pharmaceuticals Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Teva Pharmaceuticals Erythropoietin (EPO) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
